- Home
- LCFY vs APM Comparison
LCFY vs APM Comparison
Compare LCFY & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCFY
- APM
- Stock Information
- Founded
- LCFY 2009
- APM 2010
- Country
- LCFY Australia
- APM United Kingdom
- Employees
- LCFY N/A
- APM N/A
- Industry
- LCFY
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- LCFY
- APM Health Care
- Exchange
- LCFY Nasdaq
- APM Nasdaq
- Market Cap
- LCFY 5.9M
- APM 6.9M
- IPO Year
- LCFY 2022
- APM 2018
- Fundamental
- Price
- LCFY $6.95
- APM $1.81
- Analyst Decision
- LCFY
- APM
- Analyst Count
- LCFY 0
- APM 0
- Target Price
- LCFY N/A
- APM N/A
- AVG Volume (30 Days)
- LCFY 5.4M
- APM 10.1M
- Earning Date
- LCFY 08-05-2025
- APM 08-05-2025
- Dividend Yield
- LCFY N/A
- APM N/A
- EPS Growth
- LCFY N/A
- APM N/A
- EPS
- LCFY N/A
- APM N/A
- Revenue
- LCFY $2,668,385.00
- APM N/A
- Revenue This Year
- LCFY N/A
- APM N/A
- Revenue Next Year
- LCFY N/A
- APM N/A
- P/E Ratio
- LCFY N/A
- APM N/A
- Revenue Growth
- LCFY N/A
- APM N/A
- 52 Week Low
- LCFY $2.51
- APM $0.46
- 52 Week High
- LCFY $13.98
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- LCFY 67.75
- APM 64.19
- Support Level
- LCFY $4.50
- APM $1.40
- Resistance Level
- LCFY $6.85
- APM $1.97
- Average True Range (ATR)
- LCFY 0.65
- APM 0.41
- MACD
- LCFY 0.20
- APM 0.07
- Stochastic Oscillator
- LCFY 98.61
- APM 26.69
About LCFY Locafy Limited
Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.